Molecular Neurobiology

Special Issues

Following special issues within this section are currently open for submissions:

• Immunoinflammatory Background of Neuronal Damage in Ischemic Stroke (Deadline: 31 January 2020)
• Epigenetic Alterations in Neuromuscular Disorders (Deadline: 31 January 2020)
• Neuroimmunology (Deadline: 31 January 2020)
• Signalling Networks Regulating Cell Survival and Dynamics in Brain Development and Disease (Deadline: 31 January 2020)
• Orofacial Pain: Molecular Mechanisms, Diagnosis and Treatment (Deadline: 15 February 2020)
• Advances in Knowledge in Niemann-Pick Disease Type C: Facts and Perspectives (Deadline: 25 February 2020)
• Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules (Deadline: 25 February 2020)
• Synapse Formation and Modulation (Deadline: 28 February 2020)
• CNS Drug Action in Neurodegenerative Diseases (Deadline: 29 February 2020)
• Alzheimer’s Disease and Other Dementias-Novel Therapeutic Approaches (Deadline: 25 March 2020)
• Applications of Mesenchymal Stem Cells in Neuroscience (Deadline: 31 March 2020)
• Survival Pathways and Stress Tolerance Mechanisms in Senescence Programs (Deadline: 31 March 2020)
• Genetic Variants in Dopamine Receptors and Neurodegenerative Diseases (Deadline: 31 March 2020)
• Chronic Pain: Spinal and Sovraspinal Neuroinflammation and Associated Negative Affective States (Deadline: 31 March 2020)
• Choroid Plexus: Novel Functions for an Old Structure (Deadline: 31 March 2020)
• Biomarkers Guided Diagnosis and Therapy: Toward Precision Psychiatry (Deadline: 31 March 2020)
• Small Vessel Disease: A Whole Brain Disease (Deadline: 30 April 2020)
• Neurogenesis and Neural Plasticity (Deadline: 30 April 2020)
• Mechanism of Adult Neurogenesis (Deadline: 31 May 2020)
• Role of Gene Expression in the Physiology and Pathology of Neurons (Deadline: 31 May 2020)
• Neuronal, Glial, and Immune Changes in Models of Epilepsy and Epileptogenesis (Deadline: 31 May 2020)
• Glutamate Receptors in Health and Disease II (Deadline: 31 May 2020)
• Molecular and Neural Mechanisms of Swallowing (Deadline: 31 May 2020)
• Acetylcholinesterase Inhibition in Neurogenesis, Neuroinflammation and Neurodegeneration Processes (Deadline: 15 June 2020)
• Glial-Neuronal Interactions in Neurological Disorders: Molecular Mechanisms and Potential Points for Intervention (Deadline: 30 June 2020)
• Microglia: On the Cutting Edge between Health and Disease (Deadline: 30 June 2020)
• Molecular Mechanisms of Lead Neurotoxicity (Deadline: 30 June 2020)
• Molecular Mechanisms of Neural Circuit Development and Regeneration (Deadline: 31 July 2020)
• Pharmacological Study on Neuromodulatory Effects of Plant Extract (Deadline: 31 July 2020)
• Cell signaling in Neurodegeneration (Deadline: 31 July 2020)
• The Risks of Ignoring the Invisible Damages of Concussion: From Molecules to Pathology (Deadline: 31 July 2020)
• Molecular Basis and Molecular Targets in Huntington’s Disease (Deadline: 31 July 2020)
• Precision Medicine and Therapy for Neurodegenerative Disorders (Deadline: 31 July 2020)
• Zebrafish Models of Neurological Diseases and Disorders (Deadline: 31 July 2020)
• Non-genetic modifiers of synaptic plasticity and neurotransmission in the Central Nervous System (CNS) in health and disease (Deadline: 31 August 2020)
• Prions and Prion Diseases (Deadline: 31 August 2020)
• Neuroregeneration and Brain Repair after Stroke (Deadline: 31 August 2020)
• Functional Modification of Neuronal Networks (Deadline: 31 August 2020)
• Molecular Treatment in Optic Neuropathies (Deadline: 31 August 2020)
• Neurons and Surrounding Environments in Neurological Disorders and Brain Damages (Deadline: 31 August 2020)
• Neuroregenerative and Neuroprotective Strategies Based on Smart Nanomaterials (Deadline: 31 August 2020)
• Molecular Mechanisms and Neural Correlates of General Anesthesia (Deadline: 31 October 2020)